
New agents: Great expectations not realized
Keywords: acute myeloid leukemia, AML; CPX-351; FLAM; flavopiridol; FLT3 inhibitor; gemtuzumab; tipifarnib; lintuzumab; laromustine; lestaurtinib; midostaurin; AC220; clofarabine; quizartinib; sapacitabine